Huma Therapeutics
Latest round
- Series C
Last raised
- May 2021
Total raised
- $156M
Investors
- 12
About Huma Therapeutics
Founded in 2011 and based in London, UK, uma Therapeutics GmbH, operates as a provider of mobile health solution that delivers patient information and clinical applications to doctors. The company was founded by its CEO Dan Vahdat, and Rich Khatib. As of 2023, the company employs more than 500 employees.92 million post-money. Huma provides healthcare applications and solutions that combine health data from existing hospital databases as well as patient wearables and other mobile devices and securely transmits it for use by doctors via iPads and other mobile devices. By using the application, Healthcare professionals can securely access lab results, images, clinical notes, and primary care data, and hospitals can convert their patient data into a single platform so that it can be accessed by doctors in real-time when they are consulting a patient. The firm’s offerings also allow patients to send photos, take video conferences, share primary records, and transmit their real-time vital signs with biomarker devices such as apple watch with their doctors. The company offers various platforms such as hospital at home, virtual wards, remote patient monitoring USA, decentralized clinical trials, and companion apps for pharma and medtech.
Who invested in Huma Therapeutics
12 investors across 3 rounds
See all investors in Huma Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Huma Therapeutics
Who invested in Huma Therapeutics?
Huma Therapeutics has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Huma Therapeutics raised?
Huma Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Huma Therapeutics last raise money?
Huma Therapeutics's most recent round on record is a Series C, in May 2021.
What does Huma Therapeutics do?
Founded in 2011 and based in London, UK, uma Therapeutics GmbH, operates as a provider of mobile health solution that delivers patient information and clinical applications to doctors.
Where is Huma Therapeutics headquartered?
Huma Therapeutics is headquartered in Munich, Germany.
Which VCs invest in companies like Huma Therapeutics?
Among active investors with capital left to deploy, Index Ventures, European Investment Bank, Highland Europe and Marktlink Capital back software companies at Huma Therapeutics's stage. Their profiles are linked below.
VCs backing software startups at Series C
Raising like Huma Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.